BOLT
HEALTHCAREBolt Biotherapeutics Inc
$4.59-0.07 (-1.50%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving BOLT Today?
No stock-specific AI insight has been generated for BOLT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$3.91$9.25
$4.59
Fundamentals
Market Cap$9M
P/E Ratio—
EPS$-17.85
Dividend Yield—
Dividend / Share—
ROE-0.8%
Profit Margin—
Debt / Equity—
Trading
Volume16K
Avg Volume (10D)—
Shares Outstanding1.9M
BOLT News
20 articles- Bolt Metals Corp. Announces Appointment of Chief Financial Officer and Corporate SecretaryYahoo Finance·Apr 9, 2026
- Bolt Biotherapeutics, Inc. (BOLT) Reports Q4 Loss, Tops Revenue EstimatesYahoo Finance·Mar 12, 2026
- Bolt Biotherapeutics Inc.: Q4 Earnings SnapshotYahoo Finance·Mar 12, 2026
- Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business UpdateYahoo Finance·Mar 12, 2026
- Bolt Biotherapeutics to Participate in Upcoming March ConferencesYahoo Finance·Feb 24, 2026
- Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Beats Revenue EstimatesYahoo Finance·Nov 12, 2025
- Bolt Biotherapeutics Inc.: Q3 Earnings SnapshotYahoo Finance·Nov 12, 2025
- Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business UpdateYahoo Finance·Nov 12, 2025
- Bolt Biotherapeutics, Inc. (BOLT) Expected to Beat Earnings Estimates: Should You Buy?Yahoo Finance·Nov 4, 2025
- Sector Update: Health Care Stocks Retreat Late AfternoonYahoo Finance·Oct 2, 2025
- Washington Shutdown Continues as US Equity Futures Trade Mixed Ahead of Opening BellYahoo Finance·Oct 2, 2025
- Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027Yahoo Finance·Oct 1, 2025
- Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue EstimatesYahoo Finance·Aug 14, 2025
- Bolt Biotherapeutics Inc.: Q2 Earnings SnapshotYahoo Finance·Aug 14, 2025
- Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business UpdateYahoo Finance·Aug 14, 2025
- ANI Pharmaceuticals (ANIP) Q2 Earnings and Revenues Surpass EstimatesYahoo Finance·Aug 8, 2025
- Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue EstimatesYahoo Finance·Aug 7, 2025
- Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 12, 2025
- Bolt Biotherapeutics Inc.: Q1 Earnings SnapshotYahoo Finance·May 12, 2025
- Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business UpdateYahoo Finance·May 12, 2025
All 20 articles loaded
Price Data
Open$5.01
Previous Close$4.66
Day High$5.02
Day Low$4.66
52 Week High$9.25
52 Week Low$3.91
52-Week Range
$3.91$9.25
$4.59
Fundamentals
Market Cap$9M
P/E Ratio—
EPS$-17.85
Dividend Yield—
Dividend / Share—
ROE-0.8%
Profit Margin—
Debt / Equity—
Trading
Volume16K
Avg Volume (10D)—
Shares Outstanding1.9M
About Bolt Biotherapeutics Inc
Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the discovery, development and commercialization of pharmaceutical products. The company is headquartered in Redwood city, California.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—